Insights & Updates in the Treatment and Prevention of Clostridium difficile Infection: A CME Series

Sponsored by the Academy for Continued Healthcare Learning (ACHL).

This activity is supported in part by an independent education grant from Merck & Company.

Specialty: Gastroenterology, Infectious Disease, Internal Medicine, Emergency Medicine, Surgery, Primary Care, Geriatrics, Critical/Intensive Care

Activity Purpose: Clostridium difficile infection (CDI) is associated with significant morbidity and mortality. Further, recurrence of CDI is common after an initial episode. Although a number of therapies with varying mechanisms of action, are available to treat CDI and prevent recurrence, the management of CDI is complex and challenging. Clinicians require up-to-date knowledge of evidence-based treatment of initial and recurrent CDI to improve clinical outcomes.

Target Audience: This series is intended for gastroenterologists, infectious disease specialists and other healthcare professionals that treat C. diff infections.

This series consists of 5 CME activities. As each activity becomes available, the links below will direct learners to activity details and content.


Activity 1


Activity 2


Activity 3


Activity 4